Terms: = Head and neck cancer AND RAD21, HR21, 5885, ENSG00000164754, KIAA0078, FLJ25655, hHR21, MCD1, O60216, NXP1, HRAD21, FLJ40596, SCC1 AND Prognosis
3 results:
1. Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.
Wu ZH; Fang M; Zhou Y
PLoS One; 2020; 15(7):e0236678. PubMed ID: 32716971
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.
Lindsay CD; Kostiuk MA; Harris J; O'Connell DA; Seikaly H; Biron VL
Clin Epigenetics; 2017; 9():95. PubMed ID: 28878842
[TBL] [Abstract] [Full Text] [Related]
3. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
Macha MA; Rachagani S; Qazi AK; Jahan R; Gupta S; Patel A; Seshacharyulu P; Lin C; Li S; Wang S; Verma V; Kishida S; Kishida M; Nakamura N; Kibe T; Lydiatt WM; Smith RB; Ganti AK; Jones DT; Batra SK; Jain M
Oncotarget; 2017 Mar; 8(13):20961-20973. PubMed ID: 28423495
[TBL] [Abstract] [Full Text] [Related]